Search results
Sarepta (SRPT) Stock Up 76.8% in Three Months: Here's Why
Zacks via Yahoo Finance· 2 years agoSarepta Therapeutics (SRPT) is progressing with the development of its pipeline, which focuses on...
Why Sarepta's (SRPT) Stock Price Moved Up 17% on Tuesday
Zacks via Yahoo Finance· 5 months agoSarepta (SRPT) surges after its CEO made positive comments on the label expansion filing for the...
Sarepta (SRPT) Q2 Earnings Miss, DMD Drugs' Sales Robust
Zacks via Yahoo Finance· 2 years agoStrong demand for Sarepta's (SRPT) DMD drugs boosts the top line in the second quarter. However, the...
1 of Sarepta Therapeutics' Competitors Just Got Hammered. Will It Help the Stock?
Motley Fool via Yahoo Finance· 4 months agoIn biotech, it's often difficult to tell whether bad news for one company will also be bad news for...
Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Q4 2022 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 1 year agoSarepta Therapeutics, Inc. (NASDAQ:SRPT) Q4 2022 Earnings Call Transcript February 28, 2023...
Sarepta (SRPT) Down on Clinical Hold on DMD Candidate SRP-5051
Zacks via Yahoo Finance· 2 years agoThe FDA places Sarepta's (SRPT) next-generation DMD candidate, SRP-5051, on clinical hold, following...
Could Sarepta Therapeutics Become the Next Vertex Pharmaceuticals?
Motley Fool via Yahoo Finance· 4 months agoSarepta Therapeutics (NASDAQ: SRPT) and Vertex Pharmaceuticals (NASDAQ: VRTX) have a lot in common:...
A Comprehensive Look at Sarepta's Growth and Innovation
GuruFocus.com via Yahoo Finance· 3 months agoSarepta Therapeutics, Inc. (NASDAQ:SRPT) is an American pharmaceutical company leading the global...
Why Sarepta Therapeutics Stock Is Soaring Today
Motley Fool via Yahoo Finance· 4 months agoShares of Sarepta Therapeutics (NASDAQ: SRPT) were soaring 10.4% higher as of 10:58 a.m. ET on Friday. The big gain came after the biopharmaceutical...
Sarepta's (SRPT) DMD Gene Therapy BLA Gets FDA Priority Review
Zacks via Yahoo Finance· 2 years agoThe FDA accepts Sarepta's (SRPT) regulatory filing seeking accelerated approval for SRP-9001, a gene...
